HIV-tuberculosis coinfection;Co-infection tuberculose-VIH

Annales de Medecine Interne

Volumn 153, Issue 2, 2002, Pages 113-118

  Bévilacqua, Sibylle ^a   Rabaud, Christian ^a   May, Thierry ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

Coinfection; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AFRICA; BCG VACCINATION; COMORBIDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PATIENT COMPLIANCE; PROGNOSIS; REVIEW; SOUTHEAST ASIA; TUBERCULOSIS; ANTIBIOTIC RESISTANCE;

DRUG RESISTANCE, BACTERIAL; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 0036274999     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Global Tuberculosis
2. Incidence of tuberculosis in the United States among HIV-infected persons
3. Les cas de tuberculose déclarés en France en 1998 et 1999
4. Prospects for worldwide tuberculosis control under the WHO DOTS strategy
5. Relationship of the manifestation of tuberculosis to CD4 cell counts in patient with HIV infection
6. Tuberculosis and HIV
7. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with HIV type 1
8. Interaction between Mycobacterium avium and HIV type 1 in bronchoalveolar macrophages of normal and HIV-1 infected subjects
9. Increased release of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis
10. Preferential recruitment of phagocytes into the lung of patients with advanced acquired immunodeficiency syndrome and tuberculosis
11. Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV
12. Effect of Mycobacterium tuberculosis on HIV replication: Role of immune activation
13. Characteristics of sputum smear positive tuberculosis patients with and without HIV infection in a Hospital in Zimbabwe
14. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression
15. Radiographic appearance of tuberculosis in patients with AIDS and Pre-AIDS
16. Abdominal tuberculosis in patients infected with HIV
17. Tuberculosis meningitis in patients with and without HIV
18. Tuberculosis in patients with HIV infection
19. Comparative histopathological study of pulmonary tuberculosis in HIV infected and no-infected patients
20. Rapid diagnostic tests for tuberculosis: Progress but no gold standard
21. Rapid diagnostic tests for tuberculosis: What is the appropriate use?
22. Targeted tuberculin testing and treatment of latent tuberculosis infection
23. Treatment of tuberculosis and tuberculosis infection in adults and children
24. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months
25. Relapse of tuberculosis after treatment in immunodeficiency virus-infected patients
26. Prevention and treatment of tuberculosis among patients infected with HIV: Principles of therapy and revised recommendations
27. Concurrent ritonavir and rifabutin increases risk of rifabutin-associated adverse effects
28. HIV protease inhibitors: A review for clinicians
29. Impact of HIV protease inhibitors on the treatment of HIV infected tuberculosis patients with rifampicin
30. Indinavir drug interaction studies
31. Rifampin-based regimens and standard dose of nevirapin for the treatment of patients with tuberculosis and HIV infection
32. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
33. HAART in HIV-infected patients: Restoration of antigen specific CD4 T-cell responses in vitro is correlated with CD4 memory T cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia
34. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine and ritonavir. Results of AIDS Clinical Trials Group protocol 315
35. Positive effects of combined antiretroviral therapy on CD4 + T cell homeostasis and fonction in advanced HIV disease
36. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
37. Mycobacterial lymphadenitis: Can highly active antiretroviral therapy (HAART) unmask subclinical infection?
38. Strategies for long-term success in the treatment of HIV infection
39. Drug malabsorption and resistant tuberculosis in HIV-infected patients
40. Improved outcomes for patients with multidrug-resistant tuberculosis